Autologous stem cell transplantation for the treatment of neuroblastoma in Korea.
Autologous stem cell transplantation (ASCT) for the treatment of high-risk neuroblastoma (NBL) is an accepted method for restoring bone marrow depression after high dose chemotherapy. We retrospectively analyzed eighty eight cases of NBL that underwent ASCT following marrow ablative therapy at 12 tr...
Main Authors: | Ryu, Kyung Ha, Ahn, Hyo Seop, Koo, Hong Hoe, Kook, Hoon, Kim, Moon Kyu, Kim, Hack Ki, Ghim, Thad, Moon, Hyung Nam, Seo, Jong Jin, Sung, Ki Woong, Shin, Hee Young, Yoo, Eun Sun, Lyu, Chuhl Joo, Lee, Young Ho, Lee, Hahng, Cho, Bin, Cho, Hyun Sang, Choi, Hyung Soo, Hah, Jeong Ok, Hwang, Tai Ju |
---|---|
Format: | Online |
Language: | English |
Published: |
Korean Academy of Medical Sciences
2003
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055035/ |
Similar Items
-
Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center.
by: Sung, Ki Woong, et al.
Published: (2002) -
Clinical Results of High-Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation in Children with Advanced Stage Rhabdomyosarcoma
by: Kim, Nam Kyun, et al.
Published: (2012) -
Incorporation of high-dose 131I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study
by: Ji Won Lee, et al.
Published: (2017-05-01) -
Myeloablative treatment supported by autologous stem cell infusion with neuroblastoma.
by: Ryu, Kyung Ha, et al.
Published: (2003) -
Iron Overload during Follow-up after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma
by: Bae, Soo Jin, et al.
Published: (2012)